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The 52nd Annual Scientific Sessions of the ACC held in
Chicago this spring presented a great deal of new informa-
tion for cardiovascular specialists. Numerous sessions were
held in a variety of topic areas. As a special feature, leaders
were selected to present the highlights of nine topic areas at
a session held on the last day of the meeting. We are pleased
to present here the highlights of the Scientific Sessions as
formulated by the experts in these topics.
Myocardial Infarction and Ischemia
Prediman K. Shah, MD, FACC
Los Angeles, California
On behalf of my colleagues in the Scientific Program
Committee, it is my honor and pleasure to present a few of
the highlights among the scientific presentations at the
annual Scientific Sessions of the American College of
Cardiology, held in March to April 2003, in the category of
Myocardial Infarction and Ischemia. I extend my sincere
apologies to many fine colleagues whose interesting and
important work could not be included in these highlights in
view of time constraints.
Immediate reduction in acute myocardial infarction (MI)
after implementation of a comprehensive smoke-free
ordinance. This study was presented by Dr. Richard Sar-
gent of St. Peter’s Hospital, Helena, Montana, at the Late
Breaking Clinical Trials session. Several studies have shown
that second-hand smoke increases the risk of fatal and
non-fatal cardiac events by as much as 30%. Second-hand
smoke rapidly induces endothelial dysfunction and creates a
prothrombotic state through activation of platelets and
platelet aggregation as well through induction of tissue
factor. The goal of the study was to determine the impact of
enactment of a smoke-free workplace and public place
ordinance on the incidence of acute MI. A municipal
ordinance was enacted on July 4, 2002, banning smoking in
all public places, such as offices, restaurants, bars, and
casinos, in Helena, Montana. In December 2002, the
ordinance was suspended because of legal challenges. Inves-
tigators tracked all patients admitted to the St. Peter’s
Hospital (the primary cardiac care center that serves 65,913
residents in Helena, Montana) with a primary or secondary
diagnosis of acute MI at discharge, for six months after
implementation of the smoke-free ordinance. Similar data
were collected through chart review for a period of four
years before the implementation of the ordinance. Investi-
gators also collected data from hospital records of patients
outside the Helena area that were not affected by the public
ban on smoking. Investigators controlled for long-term
trends and seasonal variation. The effect of smoking ban on
the incidence of acute MI was examined using multilinear
regression analysis. During an average six-month period
before the enactment of the ordinance, approximately seven
patients with acute MI were admitted per month to
From the Division of Cardiology, Cedars Sinai Medical Center, Los Angeles,
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